Absorica | Isotretinoin Capsule Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Absorica | Isotretinoin Capsule and its risk associated with lactation. We will also discuss the usage of Absorica | Isotretinoin Capsule and some common side effects associated with Absorica | Isotretinoin Capsule.

What is Absorica | Isotretinoin Capsule used for?


ABSORICA is a retinoid indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic. “Severe,” by definition, means “many” as opposed to “few or several” nodules. Because of significant adverse reactions associated with its use, ABSORICA should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. In addition, ABSORICA is indicated only for those female patients who are not pregnant, because ABSORICA can cause severe birth defects [see Contraindications (4.1)]. ABSORICA is a retinoid indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older. (1) Limitations of Use ABSORICA may only be administered to patients enrolled in the iPLEDGE Program. (1, 5.2) Limitations of Use A single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients. If a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience with isotretinoin has shown that patients may continue to improve following treatment with isotretinoin. The optimal interval before retreatment has not been defined for patients who have not completed skeletal growth [see Warnings and Precautions (5.12)]. As a part of the iPLEDGE Program, ABSORICA may only be administered to patients enrolled in the program [see Warnings and Precautions (5.2)].

Absorica | Isotretinoin Capsule while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Absorica | Isotretinoin Capsule high risk while breastfeeding
As Absorica | Isotretinoin Capsule is made of only Isotretinoin, and Isotretinoin is unsafe to use in breastfeeding we can safely reach on conclusion that Absorica | Isotretinoin Capsule is also unsafe to use while breastfeeding. Below is detailed analysis of Isotretinoin and Absorica | Isotretinoin Capsule during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers It is not known whether this drug is present in human milk. Because many drugs are present in human milk and because of the potential for serious adverse reactions in nursing infants from ABSORICA, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Absorica | Isotretinoin Capsule Breastfeeding Analsys


Isotretinoin while Breastfeeding

Unsafe

CAS Number: 4759-48-2

Retinoid which is a synthetic derivative of vitamin A. It is a cis-configuration of Tretinoin, an acid form of vitamin A.Indicated in the treatment of severe forms of acne. At latest update no published data on excretion into breast milk were found. Despite of a high plasma protein-binding capacity, it is a highly lipophilic substance, hence, it is presumed to accumulate in breastmilk. The natural form of vitamin A is readily excreted into breastmilk. In addition to being a potent teratogen (Shirazi 2015), which affects pregnancy, it has been shown to decrease all pituitary hormones levels (Karadag 2011 and 2015) along with other potential serious side effects associated to the use of Isotretinoin. It may cause galactorrhea (Larsen 1985). A safer alternative should be preferred until more published data on this drug related to breastfeeding is available, especially during the neonatal period and in case of prematurity.

Absorica | Isotretinoin Capsule Breastfeeding Analsys - 2


Isotretinoin while Breastfeeding

CAS Number: 4759-48-2

No information is available on the use of isotretinoin during breastfeeding. Various topical agents that are less likely to be absorbed by the mother may be preferred during breastfeeding, especially while nursing a newborn or preterm infant.

Absorica | Isotretinoin Capsule and breastfeeding

What should I do if I am breastfeeding mother and I am already exposed to Absorica | Isotretinoin Capsule?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Absorica | Isotretinoin Capsule usage and time interval of breastfeeding.


I am nursing mother and my doctor has suggested me to use Absorica | Isotretinoin Capsule, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Absorica | Isotretinoin Capsule then there must be good reason for that as Absorica | Isotretinoin Capsule is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Absorica | Isotretinoin Capsule, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Absorica | Isotretinoin Capsule and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Absorica | Isotretinoin Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Zenatane | Isotretinoin Capsule, Gelatin Coated
Myorisan | Isotretinoin Capsule
Amnesteem | Isotretinoin Capsule
Isotretinoin Capsule
Claravis | Isotretinoin Capsule
Absorica | Isotretinoin Capsule